Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The company was founded by Darell Bigner, MD, and Matthias Gromeier, MD, of Duke University Medical Center in 2016. Both are leaders in their respective research fields of virology, immunology, monoclonal development and clinical medicine, particularly in the treatment of brain tumors.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 6 Davis Dr, Durham,north Carolina 27709,united States
- Phone
- (919)226-3082
- in****@****ogy.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://istarioncology.com
- HQ
- Durham, North Carolina
Istari Oncology Questions
Istari Oncology's helpline number is (919)226-3082
Istari Oncology's website is http://istarioncology.com
Istari Oncology's LinkedIn profile is https://www.linkedin.com/company/istari-oncology
Istari Oncology has
9 employees.
View email and phone details for 9
employees at Istari Oncology.
Istari Oncology's industry is
Biotechnology Research
Istari Oncology's top competitors are
Polaris Pharmaceuticals,
Aer Therapeutics, Inc.,
Abzena,
Immorna,
Locus Biosciences, Inc.,
Ribometrix Inc.,
Tavros Therapeutics,
Alcami Corporation,
Adverum Biotechnologies,
Stridebio, Inc.
Istari Oncology's support email address is info@istarioncology.com
Istari Oncology's categories are Biotechnology Research
Istari Oncology's founding year is 2016
